No sale: After 3 years of hunting a buyer, bruised Trulance maker Sy...

10/26/18


FiercePharma

No sale: After 3 years of hunting a buyer, bruised Trulance maker Synergy desperate for cash
FiercePharma
If it can't renegotiate terms with its lender, bankruptcy could be next. At Trulance's current sales pace, Synergy said it won't be able to meet minimum revenue requirements of a loan agreement with investor CRG Servicing. As a buyer willing to meet ...
Synergy Pharmaceuticals (SGYP) May Be Filing for Bankruptcy — and Its Stock Price Is Now Around 40 CentsSmarter Analyst
Synergy Pharma (SGYP) Provides Update on Review, Said Offers 'Significantly Below' Current Market ValueStreetInsider.com

all 76 news articles »

[more]